A positive QuantiFERON Gold test means your immune system has been exposed to the bacteria that cause tuberculosis (TB). Specifically, the test detected that your white blood cells released a measurable immune response when exposed to TB-specific proteins, with a result at or above 0.35 IU/mL. This does not necessarily mean you have active TB disease. Most people with a positive result have what’s called latent TB infection, meaning the bacteria are present in the body but dormant, causing no symptoms and posing no risk of spreading to others.
The test result is a starting point, not a diagnosis. What happens next depends on additional evaluation, including imaging and a symptom review.
How the Test Works
The QuantiFERON Gold is a blood test, part of a category called interferon-gamma release assays (IGRAs). A blood sample is drawn and mixed with proteins that are unique to the TB-causing bacterium, Mycobacterium tuberculosis. If you’ve been infected at any point, your T cells (a type of white blood cell central to immune defense) will recognize those proteins and release a signaling molecule called interferon-gamma. The lab measures how much interferon-gamma your cells produce. If it meets or exceeds 0.35 IU/mL, the result is positive.
This process mirrors what happens inside your body during a real infection. When TB bacteria enter the lungs, immune cells called macrophages engulf them and recruit T cells for help. The T cells release interferon-gamma, which supercharges the macrophages. This back-and-forth cycle continues until the infection is either cleared or forced into dormancy. The QuantiFERON test essentially recreates this reaction in a tube to see whether your T cells “remember” TB.
Why It’s Preferred Over the Skin Test
The older tuberculin skin test (TST) works on a similar principle but has a significant drawback: it cross-reacts with the BCG vaccine, a TB vaccine given routinely in many countries outside the United States. If you received BCG as a child, a skin test can come back positive even if you’ve never been infected with TB. The QuantiFERON Gold uses proteins specific to Mycobacterium tuberculosis that aren’t found in BCG vaccine strains, so prior vaccination does not cause false positives. For anyone who has received BCG, the QuantiFERON Gold is the preferred testing method.
Latent TB vs. Active TB
A positive result tells you that your body has encountered TB bacteria. It does not tell you whether the infection is latent or active. That distinction matters enormously. Latent TB means the bacteria are alive but contained by your immune system. You feel fine, have no symptoms, and cannot pass TB to anyone else. Roughly 5 to 10 percent of people with untreated latent TB will eventually develop active disease at some point in their lives, with the risk being highest in the first two years after infection.
Active TB disease, by contrast, means the bacteria are multiplying and causing damage, most commonly in the lungs. Symptoms include a persistent cough lasting three weeks or more, chest pain, coughing up blood, unexplained weight loss, night sweats, and fever. Active TB is contagious. Interestingly, the QuantiFERON test can sometimes be less reliable in people with active TB, because the disease itself can suppress the immune response the test measures.
What Happens After a Positive Result
A positive QuantiFERON Gold triggers a complete medical evaluation with five components: a medical history review, a physical exam, confirmation of the positive test, a chest X-ray, and, if active disease is suspected, laboratory examination of sputum (the mucus you cough up from your lungs). The chest X-ray is the key next step for most people. If the X-ray looks normal and you have no symptoms, latent TB is the most likely diagnosis.
If the X-ray shows abnormalities or you have TB symptoms, your provider will collect sputum samples for microscopy and culture testing. These tests look for the bacteria directly and can also determine which medications the bacteria respond to.
Treatment for Latent TB
If you’re diagnosed with latent TB, treatment is recommended to prevent the infection from becoming active disease down the line. Several regimens are available, and the trend in recent years has been toward shorter courses. The CDC’s preferred options include a 3-month regimen taken once weekly, a 4-month daily regimen, or a 3-month daily combination regimen. These shorter treatments have higher completion rates and fewer side effects than the older approach of taking a single medication daily for 6 to 9 months.
The 6- or 9-month daily regimens are still used as alternatives but carry a higher risk of liver-related side effects and are harder to stick with over time, which reduces their real-world effectiveness. Your provider will choose a regimen based on your health profile, other medications you take, and any drug interactions. Throughout treatment, you’ll typically have periodic check-ins to monitor for side effects, particularly liver inflammation.
When Results Are Unclear
Not every QuantiFERON result falls neatly into positive or negative. Results between 0.20 and 0.34 IU/mL are technically negative but sit in a borderline zone where test variability could push the number either way on a repeat draw. Results at 0.35 to 0.99 IU/mL are positive but considered borderline positive by some researchers. Values at or above 1.0 IU/mL are more definitively positive. If your result lands in a borderline range, your provider may recommend repeating the test.
The test can also return an indeterminate result, meaning it couldn’t be interpreted at all. This typically happens when the positive control in the test (a substance that should always trigger a response) fails to produce one. Common causes include immunosuppressive medications like corticosteroids or TNF-alpha inhibitors, low white blood cell counts, severe illness, or even improper handling of the blood sample before it reached the lab. An indeterminate result is not the same as negative. It simply means the test didn’t work properly and needs to be repeated or supplemented with a skin test.
Accuracy in Different Populations
In the general population, the QuantiFERON Gold performs well, with sensitivity around 92 percent and specificity around 62 percent for detecting active TB. Sensitivity refers to how reliably it catches true infections; specificity refers to how well it avoids flagging people who don’t have TB. The relatively modest specificity means some positive results, particularly borderline ones, may not reflect true TB infection.
The test is less reliable in people with weakened immune systems. People living with HIV, especially those with low CD4 counts, produce a diminished interferon-gamma response, which can lead to falsely negative or indeterminate results. The same applies to people on immunosuppressive therapy for autoimmune conditions, organ transplant recipients, and those with diabetes. In these groups, a negative result provides less reassurance, and a positive result still warrants full evaluation, but providers may use additional tools to get a clearer picture.
Can a Positive Result Go Away?
Once you test positive, you will likely continue to test positive on future QuantiFERON tests even after completing treatment for latent TB. Treatment eliminates or greatly reduces the live bacteria, but your T cells retain their memory of the infection. That immunological memory is exactly what the test detects. For this reason, repeating the QuantiFERON Gold after treatment is generally not useful for confirming that treatment worked. Success is measured by completing the full course of medication and remaining free of symptoms and X-ray changes over time.